Cambridge Biomedical's top scientific team.
Each one of our technical experts has a proven track record of excellence in their fields. They are uniquely positioned to assist you throughout every phase of your project.
Dr. Robbie is the Vice President of Scientific Affairs, responsible for leading all Cambridge Biomedical Bioanalytical Services. She directs all initiatives for Cambridge Biomedical as they relate to science, technology, and laboratory operations.
Dr. Tinghitella is the Medical Director for the CLIA Licenced, CAP accredited medical laboratory at Cambridge Biomedical. He serves as the medical liaison for all clients, physicians, and their patients, and provides clinical consults as requested.
Dr. Bronfin is the Director of Clinical Research and Development at Cambridge Biomedical Inc. He has experience with a wide range of technologies including: PCR and qPCR, DNA sequencing, cell-based assays, ELISA, RIA, microbiology, protein and antibody expression and characterization. Dr. Bronfin received his MD from Medical Academy, Omsk, Russia.
Dr. Bond is a Director of Technical Affairs at Cambridge Biomedical Inc. She is primarily responsible for all PCR and cell based assays at CBI, and has extensive experience in cell biology, molecular biology, and histological techniques. Dr. Bond holds a Ph.D. in Cellular and Molecular Physiology from Tufts University School of Medicine and a B.S. in Biology from Ohio University.
Full Biography Incoming
Dr. Mangada was trained as a T cell immunologist and molecular virologist and has more than 16 years’ experience in flow cytometry and other immunoassays, T cell immunology, virology, infectious diseases, vaccines and molecular biology. Dr. Mangada received his Doctorate in Molecular Virology from Nagasaki University, Japan.
John has over 18 years’ experience in life sciences including DNA chemistry, High Content Screening, vendor management, laboratory automation, and de novo antibody generation. He has presented his work numerous times including: 'Synthesis of Oligonucleotides with Special Modifications’, ‘SNP Genotyping using Maldi-TOF Analysis to Facilitate Pharmacogenomics’, and ‘Automation Inside and Outside of the Lab: Finding Better and Faster Ways of Sequencing DNA and Delivering Base-Perfect Data’.